- Home
- PFE vs BTI Comparison
PFE vs BTI Comparison
Compare PFE & BTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PFE | BTI |
|---|---|---|
| Founded | 1849 | 1902 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.4B | 124.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PFE | BTI |
|---|---|---|
| Price | $25.11 | $57.24 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | $27.40 | ★ $62.00 |
| AVG Volume (30 Days) | ★ 48.3M | 3.1M |
| Earning Date | 02-03-2026 | 02-15-2026 |
| Dividend Yield | ★ 6.86% | 5.31% |
| EPS Growth | ★ 131.89 | N/A |
| EPS | 1.73 | ★ 1.89 |
| Revenue | ★ $62,785,000,000.00 | $35,067,817,512.00 |
| Revenue This Year | N/A | $0.27 |
| Revenue Next Year | N/A | $3.18 |
| P/E Ratio | ★ $14.58 | $29.64 |
| Revenue Growth | ★ 3.89 | N/A |
| 52 Week Low | $20.92 | $34.82 |
| 52 Week High | $27.69 | $59.29 |
Technical Indicators
Market Signals| Indicator | PFE | BTI |
|---|---|---|
| Relative Strength Index (RSI) | 46.10 | 54.49 |
| Support Level | $24.83 | $56.20 |
| Resistance Level | $25.52 | $57.20 |
| Average True Range (ATR) | 0.54 | 0.68 |
| MACD | -0.10 | -0.20 |
| Stochastic Oscillator | 11.81 | 37.70 |
Price Performance
Historical ComparisonAbout PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
About BTI British American Tobacco Industries p.l.c. ADR
The third-largest tobacco company by volume, British American Tobacco sold 518 billion cigarettes in 2024. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the US. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 22.9% stake in ITC limited, the largest Indian cigarette company.